CNS and Neurological Disorders - Drug Targets Impact factor 2025

---

The latest impact factor of CNS and Neurological Disorders - Drug Targets and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

CNS and Neurological Disorders - Drug Targets: Aim & Scope

CNS and Neurological Disorders - Drug Targets is a Web of Science indexed journal tha publishes research in the area: Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3).
The ISSN of this journal is 19963181.

Impact factor of CNS and Neurological Disorders - Drug Targets

Journal Title	CNS and Neurological Disorders - Drug Targets
Impact Factor
SJR	0.574
ISSN	19963181
Quartile	Q2

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

CNS and Neurological Disorders - Drug Targets

ISSN: 19963181
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS

ISSN: 1996-3181
Journal Impact: 2.7
Journal Scope: Neurosciences | Pharmacology & Pharmacy

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

ISSN: 22147527, 24518883
Journal Impact:
Journal Scope: Neurology (clinical); Pharmaceutical Science; Pharmacology (medical)

Endocrine, Metabolic and Immune Disorders - Drug Targets

ISSN: 22123873
Journal Impact:
Journal Scope: Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)

Cardiovascular and Hematological Disorders - Drug Targets

ISSN: 22124063
Journal Impact:
Journal Scope: Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)

Infectious Disorders - Drug Targets

ISSN: 22123989
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS

ISSN: 2212-3873
Journal Impact: 2
Journal Scope: Endocrinology & Metabolism | Immunology | Pharmacology & Pharmacy

primary care companion for CNS disorders, The

ISSN: 21557780
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3); Psychiatry and Mental Health (Q3)

The Primary Care Companion for CNS Disorders

ISSN: 2155-7780
Journal Impact:
Journal Scope:

CNS Drug Reviews

ISSN:
Journal Impact:
Journal Scope:

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?